Loading clinical trials...
Loading clinical trials...
IVIG Versus Plasmapheresis and Guillian Barrie Syndrome
Conditions
Interventions
plasmapheresis device
Intravenous immunoglobulin
Locations
1
Egypt
Assiut university
Asyut, Egypt
Start Date
September 1, 2021
Primary Completion Date
March 2, 2022
Completion Date
March 3, 2023
Last Updated
April 6, 2023
NCT06200454
NCT05491096
NCT05630313
NCT05324176
NCT03826056
NCT04550611
Lead Sponsor
Assiut University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions